Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Reinares

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Psychiatry|July 24, 2001
Topiramate abuse in a bipolar patient with an eating disorderF Colom, E Vieta, A Benabarre, et al.
The Journal of Clinical Psychiatry|September 20, 2001
Reboxetine-induced hypomaniaE Vieta, F Colom, A Martínez-Arán, et al.
Bipolar Disorders|March 21, 2002
Clinical correlates of psychiatric comorbidity in bipolar I patientsE Vieta, F Colom, B Corbella, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 12, 2000
Adjunctive gabapentin treatment of bipolar disorderE Vieta, A Martinez-Arán, E Nieto, et al.
Journal of Affective Disorders|March 1, 2002
Role of risperidone in bipolar II: an open 6-month studyE Vieta, C Gastó, F Colom, et al.
Psychotherapy and Psychosomatics|July 5, 2002
The somatics of psyche: structural neuromorphometry of bipolar disorderA Benabarre, E Vieta, A Martinez-Arán, et al.
Psychotherapy and Psychosomatics|December 12, 2001
Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcomeA Martínez-Arán, R Penadés, E Vieta, et al.
The Journal of Clinical Psychiatry|September 20, 2001
Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD)E Vieta, M Herraiz, A Fernández, et al.
Bipolar Disorders|October 18, 2005
Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levelsF Colom, E Vieta, J Sánchez-Moreno, et al.
Journal of Clinical Psychopharmacology|October 11, 2001
Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorderE Vieta, M Reinares, B Corbella, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Psychiatry|July 24, 2001
Topiramate abuse in a bipolar patient with an eating disorderF Colom, E Vieta, A Benabarre, et al.
The Journal of Clinical Psychiatry|September 20, 2001
Reboxetine-induced hypomaniaE Vieta, F Colom, A Martínez-Arán, et al.
Bipolar Disorders|March 21, 2002
Clinical correlates of psychiatric comorbidity in bipolar I patientsE Vieta, F Colom, B Corbella, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 12, 2000
Adjunctive gabapentin treatment of bipolar disorderE Vieta, A Martinez-Arán, E Nieto, et al.
Journal of Affective Disorders|March 1, 2002
Role of risperidone in bipolar II: an open 6-month studyE Vieta, C Gastó, F Colom, et al.
Psychotherapy and Psychosomatics|July 5, 2002
The somatics of psyche: structural neuromorphometry of bipolar disorderA Benabarre, E Vieta, A Martinez-Arán, et al.
Psychotherapy and Psychosomatics|December 12, 2001
Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcomeA Martínez-Arán, R Penadés, E Vieta, et al.
The Journal of Clinical Psychiatry|September 20, 2001
Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD)E Vieta, M Herraiz, A Fernández, et al.
Bipolar Disorders|October 18, 2005
Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levelsF Colom, E Vieta, J Sánchez-Moreno, et al.
Journal of Clinical Psychopharmacology|October 11, 2001
Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorderE Vieta, M Reinares, B Corbella, et al.
Pageof 6